Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

The method can measure multiple steroids in human hair to study long-term steroid metabolism, especially in newborns and children.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.